Edition:
United Kingdom

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,600.00GBp
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
4,600.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,051,117
52-wk High
4,780.00
52-wk Low
2,940.50

Select another date:

Fri, Nov 16 2018

EU mergers and takeovers (Nov 16)

BRUSSELS, Nov 16 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON Banks, law firms and other advisers stand to earn up to $963 million (£749.3 million) in fees from Takeda Pharmaceutical's $62 billion (48.3 billion pounds) takeover of drugmaker Shire , according to documents for the deal published on Monday.

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday.

Takeda's Shire takeover to bring $963 million fee bonanza

LONDON, Nov 12 Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire, according to documents for the deal published on Monday.

Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8

LONDON Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support.

Takeda sets vote date, aims to close $62 billion Shire deal on January 8

LONDON Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion (47.92 billion pounds) acquisition of Shire next month and aims to close the deal on Jan. 8, signalling its confidence in securing the required support.

UPDATE 1-Takeda sets vote date, aims to close $62 bln Shire deal Jan. 8

* EU, last key regulator, expected to clear acquisition (Adds latest shares, CEO quote, further detail)

Takeda sets vote date, aims to close $62 bln Shire deal Jan. 8

LONDON, Nov 12 Takeda Pharmaceutical will seek investor backing for its $62 billion acquisition of London-listed Shire next month and aims to close the deal on Jan. 8, the Japanese drugmaker said on Monday.

Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources

BRUSSELS Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday.

Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources

BRUSSELS Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion (47.7 billion pounds) bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday.

Select another date: